CoChat

p16 a biomarker of aging and tolerance for cancer therapy

Open access
Muss, Hyman B., Smitherman, Andrew, Wood, William A., Nyrop, Kirsten, Tuchman, Sascha, Randhawa, Paramjeet K., Entwistle, Amy R., Mitin, Natalia, Shachar, Shlomit S. · 2020 · Translational Cancer Research
Cited by 69

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

There is great variability in life-expectancy, physical, cognitive, and functional domains in cancer patients of similar chronologic age. Nowhere is this more apparent than among middle-aged and older patients. However, even in younger patients of similar age, extensive exposure to environmental stressors can cause great variability in health status. A biomarker that would reflect biologic age and any and all health deficits in a cancer patient at a distinct point in time might help predict long term outcomes related to treatment, especially toxicity and overall survival. p16 INK4a (hereafter referred to as p16) expression represents an ideal biomarker that reflects both cellular senescence and biologic aging. In murine models, p16 expression reflects biologic aging in almost all organs. Preliminary findings in patients with cancer support p16 measurement as a marker of physiologic aging and predictor of toxicity in patients treated with chemotherapy. This review describes the role of p16 in cell senescence, the methodology of p16 measurement in humans, preliminary studies of p16 in humans, and the potential clinical utility of p16 in guiding treatment for cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.21037/tcr.2020.03.39

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 69

Metadata

Authors
Muss, H. B., Smitherman, A., Wood, W. A., Nyrop, K., Tuchman, S., Randhawa, P. K., Entwistle, A. R., Mitin, N., & Shachar, S. S.
Venue
Translational Cancer Research
Published
2020-09
Volume
9
Issue
9
Pages
5732-5742
ISSN
  • 2218-676X (ISSN-L)
  • 2219-6803
OpenAlex
W3013569279
Cited by
69
References
37
FWCI
3.02
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p16 a biomarker of aging and tolerance for cancer therapy. https://app.cochat.ai/papers/10.21037/tcr.2020.03.39
The paper
Muss, H. B., Smitherman, A., Wood, W. A., Nyrop, K., Tuchman, S., Randhawa, P. K., Entwistle, A. R., Mitin, N., & Shachar, S. S. (2020). p16 a biomarker of aging and tolerance for cancer therapy. Translational Cancer Research. https://doi.org/10.21037/tcr.2020.03.39

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.